(Almost) 10 years of HMRs : 05/08/2010 :

The announcement in May that the Home Medicine Review Divisional Facilitator Program would not be refunded as part of the 5th Community Pharmacy Agreement saw AusPharm receive a few emails lamenting its passing but, at the same time, engendered some fond reminiscing from our correspondents.

You need to log in to read the rest of this article. Click here for details

---

Rate of diagnosis of Type I diabetes in children has steadied : 05/08/2010 :

The AIHW has released a 35-page report showing that since 2005 the rate of new cases of Type 1 diabetes in Australian children has steadied, as compared with the beginning of the decade when the incidence increased by about 6% each year (2000 - 2004).

There were over 8,000 new cases of Type 1 diabetes diagnosed in Australian children between 2000 and 2008, an average of two new cases every day.

According to Anne-Marie Waters of the AIHW's Cardiovascular, Diabetes and Kidney Unit, the figures suggest that "the incidence of Type 1 diabetes in children is stable at present. However, Australia still remains in the top 10 OECD countries with the highest rates of Type 1 diabetes in children." The somewhat stable situation for Type 1 diabetes is in contrast to the known increase in Type 2 diabetes.

You need to log in to read the rest of this article. Click here for details

---

eRx meets mandatory national security & privacy check : 05/08/2010 :

eRx Script Exchange’s security and privacy standards have been independently validated as achieving national standards this month, with the successful completion of independent Security Assessment and Privacy Impact Assessments.

All Prescription Exchange Services (PES) are required to undertake the independent assessments as a key condition of the 5th Community Pharmacy Agreement ePrescription Incentive Payments. The assessments are guided by the National eAuthentication Framework around security and ensure that all obligations are met under the Commonwealth's Privacy Act 1988.

You need to log in to read the rest of this article. Click here for details

---

PHARMeFOOTY weekly wrap : 04/08/2010 :

AFL Round 18 proved difficult for tipsters with just the 1 tipster selecting all 8 winners. Sandy Lowcock from Figtree Plaza Chemist had the only perfect round and receives the weekly prize, congratulations Sandy. In 2nd place was Graham Priest of Lauderdale Pharmacy with Corey Gillie taking 3rd spot.

NRL Round 19 saw 5 tipsters select all 8 winners correctly. It came down to cumulative margin to determine the prize and Anthony Stanton of Blooms is the weekly winner. In 2nd was Greg Bereza from Kingscliff Village Pharmacy with Geoff Oliver of HMR Consultant taking out 3rd.

You need to log in to read the rest of this article. Click here for details

---

ASMI: association between calcium supplements and heart disease 'controversial' : 04/08/2010 :

The Australian Self Medication Industry (ASMI), the industry body representing non-prescription consumer healthcare products in Australia, issued a statement yesterday telling consumers that they should not be alarmed by recent media coverage linking calcium supplements with an increased risk of heart disease.

ASMI was responding to media coverage regarding the safety of calcium supplements following the publication of a recent article in the British Medical Journal [1]. The article suggested that the role of calcium supplements should be reassessed because they could increase a person’s risks of heart disease.

You need to be a "premium" subscriber to read the rest of this article. Click here for details

---

Generics incentives to be made public : 04/08/2010 :

The ACCC yesterday announced that it intends to grant conditional approval to the second edition of the Generic Medicines Industry Association's Code of Practice. The Code is intended to provides a self-regulatory framework to govern the relationship between generic pharmaceutical companies and healthcare professionals.

"While the ACCC is proposing to grant authorisation, this is subject to conditions to provide greater transparency around the relationship between the manufacturers of generic medicines and pharmacists," ACCC chairman Graeme Samuel said.

You need to be a "premium" subscriber to read the rest of this article. Click here for details

---

Kung Flu fighters : 04/08/2010 :

According to the Pharmacy Guild its Pandemic Influenza Preparedness Program, also known as the Kung Flu Fighter campaign, has been well received by Guild members.

Over 1800 individual pharmacies participated in the program and over 1200 pharmacy staff members registered for infection control and business planning workshops across Australia. 

Another indicator of success was the enthusiastic response to the Kung Flu Fighter “look-a-like” competition.

You need to log in to read the rest of this article. Click here for details

---

AHPRA / Board apologises for delays : 04/08/2010 :

In a statement posted on its website yesterday, the Australian Health Practitioner Regulation Agency (AHPRA) acknowledged the difficulty people were having contacting the agency and apologised for the delays.

"We know that sometimes it has been difficult to reach AHPRA on 1300 419 495 due to the exceptionally high call volumes we are experiencing. We apologise for any delays that you may have experienced. We are working hard to ensure that your phone and email queries are dealt with as quickly as possible."

The Pharmacy Board has posted a series of FAQs on its website (here) that may answer some of the questions people are unable get answered through inability to contact AHPRA by phone.

You need to log in to read the rest of this article. Click here for details

---

Medicines Safety Update focuses on Champix, Panvax : 04/08/2010 :

Medicines Safety Update No.4; 2010 (formerly the ADRAC Bulletin) has been published on the TGA website.

According to the TGA, psychiatric symptoms, including suicidal behaviour, continue to be reported with varenicline. To May 2010, there have been 206 reports of suicide-related events in people taking varenicline, including 15 completed suicides. The TGA is asking health professionals to include relevant information from the patient's history in adverse reaction reports to help in its assessment of cases, and is reminding them to discuss the possibility of these events with patients and their families.

The Update also reports on the Panvax swine flu vaccine - information is now available about the number and types of adverse reactions reported during the first six months of the program.

The Medicines Safety Update is on the TGA website here.

You need to log in to read the rest of this article. Click here for details

---

SHPA continuum of care award announced : 04/08/2010 :

Alexandra (Sasha) Bennett is the recipient of the SHPA sanofi-aventis Pamela Nieman Continuum of Care Research Grant 2010. The award provides a grant of $10,000 to a pharmacist member of SHPA ideally focusing on the development and implementation of strategies and or education to facilitate improved
continuity of care.

Sasha’s research will comprise a national, multicentre study designed to describe the nature and range of pharmacist services directed at addressing continuity of care gaps in the achievement of quality use of medicines (QUM) in patients discharged from Australian hospitals during 2010.

You need to be a "premium" subscriber to read the rest of this article. Click here for details

---

Survey - What should be on the FIP Centennial Congress agenda : 03/08/2010 :

The International Pharmaceutical Federation (FIP) was founded in 1912 and is looking forward to celebrating its centenary in 2012. The FIP centennial congress will be held in Amsterdam, 3-8 October 2012, and to make it an event worthy of the past 100 years, FIP is seeking input from pharmacists as to what they would like to see on the congress agenda.

You can offer your thoughts in a short survey, which is anonymous, unless you'd like the chance to win a free centennial congress registration by also giving your email address.

You need to log in to read the rest of this article. Click here for details

---

Patients poorly understand their type 2 diabetes management : 03/08/2010 :

Some of the results of new research on the challenges patients face in management of type 2 diabetes have been released by Novartis Australia, with endorsement by the Pharmacy Guild. The research was conducted online among a representative sample (401) of Australians aged 18-64 with type 2 diabetes, and shows a low level of understanding among patients.

The report reveals that although 67% of respondents believe they know their blood glucose (HbA1c) target, only 17% are able to identify it correctly. 1 in 3 respondents consider their diabetes to be uncontrolled, while the same proportion admits they do not know what their optimal blood glucose levels should be.

According to Guild President, Kos Sclavos, the research reveals a surprising lack of knowledge among patients about the basics of managing type 2 diabetes.

You need to log in to read the rest of this article. Click here for details

---

Efficacy of combined analgesics with less than 60mg codeine questioned : 03/08/2010 :

A recent Australian review of combination analgesics in adults, published in the August 2010 Australian Prescriber, concluded:

"...for acute postoperative pain there is evidence of efficacy for paracetamol 1g with codeine 60mg, and some evidence for paracetamol combined with codeine in hip osteoarthroses. Current guidelines do not support the use of paracetamol and codeine combination products in other acute or chronic pain states.
    There are limited data for doses of codeine less than 60mg in combination with paracetamol, and current data suggest that paracetamol alone has greater efficacy than paracetamol combined with codeine at doses under 60mg.
    Current evidence shows improved analgesia with codeine 60mg and ibuprofen 400mg compared to ibuprofen alone, but there are minimal data for lower doses.
    Indirect comparisons show that the combination of aspirin and codeine may be less efficacious than aspirin alone and therefore the combination cannot be recommended. Given the lack of documented analgesic efficacy of low-dose codeine preparations, rescheduling of codeine in Australia is unlikely to impact significantly on analgesic options, but may reduce the harms from overuse."

The NPS supports the findings of the paper, saying that they are in line with NPS reviews of evidence that show when treating acute pain, only modest additional pain relief is achieved when codeine is added to other analgesics.

You need to log in to read the rest of this article. Click here for details

---

RADAR reservations on paracetamol/caffeine product : 03/08/2010 :

With the availability of Panadol Extra (paracetamol/caffeine) as a pharmacy-only medicine for temporary pain relief from 1 May 2010, the August issue of RADAR includes timely advice and reservations about the use of this OTC product. The article reports that although caffeine is claimed to enhance the efficacy of paracetamol, peak plasma levels and extent of absorption are similar for paracetamol with caffeine and paracetamol alone. Compared with paracetamol alone, a person taking the combination of paracetamol with caffeine may be more likely to experience adverse effects than to get improved analgesia.

Other items in this issue of RADAR include:

• Gliptins for type 2 diabetes mellitus, with the addition of Vildagliptin (Galvus)  to the PBS. Like sitagliptin (Januvia), it can be prescribed with metformin or a sulfonylurea when a combination of these drugs is contraindicated or not tolerated.
• A new adrenaline autoinjector (Anapen) for emergency treatment of anaphylaxis. It has a substantially different administration technique to that of EpiPen.
• Methoxyflurane (Penthrox) for analgesia (doctor’s bag listing).
• Melatonin prolonged-release tablets (Circadin) for short term use in primary insomnia in people 55 years and over.
• Colchicine for acute gout - updated information about dosing and drug interactions.

RADAR, the Rational Assessment of Drugs and Research, is an NPS publication.

You need to log in to read the rest of this article. Click here for details

---

MIMS Monthly Medicine Update : 03/08/2010 :

The MIMS August 2010 Monthly Medicine Update is now available. Click the link to read it now.

You need to log in to read the rest of this article. Click here for details

---

CHOICE trial doubts value of expensive shampoos : 02/08/2010 :

A recent CHOICE trial of 11 shampoos amongst 40 panellists found that the cheaper shampoos rated more highly overall than the expensive ones, when tested for cleaning, fragrance and consistency. From an ingredient viewpoint, little difference was found between the products. The premium priced products tend to have better fragrance, packaging and marketing but the basic cleaning functionality of the products is much the same.

"Amid all the marketing hype, the basic purpose of shampoo is to clean your hair and scalp," said CHOICE spokesman Brad Schmitt. "Beyond that, shampoo is a case of personal preference, but our trial proves price is no indication of quality or popularity and with the expensive brands you could be pouring money down the drain."

The full survey can be viewed at www.choice.com.au/shampoo.

You need to log in to read the rest of this article. Click here for details

---

Flu shots for under fives can be resumed with Vaxigrip or Influvac : 02/08/2010 :

The Chief Medical Officer has issued updated advice on seasonal flu vaccination for young children (under 5 years of age).

Continued close monitoring of side effects with this year's seasonal flu vaccine in children under five has shown that the higher than usual occurrence of fever and febrile convulsions appears to be confined to Fluvax (CSL). The CMO advises parents that they can now seek advice from their doctor or vaccine provider to use other brands - Vaxigrip (Sanofi Pasteur), Influvac (Abbott) - if they want their young children vaccinated.

To date and explanation for the higher than expected observed rates of fever and febrile convulsions with Fluvax has not been found, but investigations continue.

You need to log in to read the rest of this article. Click here for details

---

New executive director takes over at ASMI : 02/08/2010 :

As announced in February, Deon Schoombie took over the executive directorship of the self-medication industry lobby group, ASMI on 30 July 2010. Former executive director Juliet Seifert has stood down after 21 years, to spend more time with family.

Since mid-2004, Dr Schoombie was ASMI's scientific director. Steven Scarff, solicitor and former regulatory affairs staffer with J&J Pacific and Pfizer Consumer Healthcare, was appointed as replacement regulatory and scientific affairs director in June 2010.

You need to log in to read the rest of this article. Click here for details

---

1 month's grace if registration due to expire : 02/08/2010 :

AHPRA has issued brief advice giving pharmacists a one month grace period if their registration is about to expire. If registration renewal has fallen due, it can be renewed online using the registration ID number and the password (posted out to registrants recently by AHPRA).

Provided pharmacist registration is renewed within one month of it falling due, pharmacists will remain registered under a grace period and can continue to work. If renewal is applied for after the one month grace period, a late fee will apply as well as the registration fee.

You need to log in to read the rest of this article. Click here for details

---

RGH E-Bulletin: Central post-stroke pain : 02/08/2010 :

The topic of this week's RGH E‑Bulletin is Central post-stroke pain.

"Central post-stroke pain (CPSP) is a chronic pain disorder resulting from a lesion or dysfunction of the central nervous system. Previously known as the "thalamic syndrome", CPSP has been shown in early post-mortem studies and modern imaging techniques to also occur in extrathalamic lesions. Frequent co-existing pain in stroke patients and variability in onset, presentation and intensity of CPSP, as well as the lack of diagnostic criteria, makes diagnosis of this disorder complex. Currently, the Western Australian Therapeutic Advisory Group recommends tricyclic antidepressants as the first line treatment for CPSP and lamotrigine as the second line approach."

Click here to read the bulletin in full. The E‑Bulletins are archived on the AusPharmList website here.

You need to log in to read the rest of this article. Click here for details

---

Click here to go to the old "Industry News" page (pre 01/09/2006).